These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15106730)

  • 1. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction.
    Plum SM; Vu HA; Mercer B; Fogler WE; Fortier AH
    Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):29-41. PubMed ID: 15106730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development.
    Plum SM; Holaday JW; Ruiz A; Madsen JW; Fogler WE; Fortier AH
    Vaccine; 2000 Dec; 19(9-10):1294-303. PubMed ID: 11137269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
    Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
    Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
    Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
    J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.
    Rusnati M; Presta M
    Int J Clin Lab Res; 1996; 26(1):15-23. PubMed ID: 8739851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes.
    Duraisamy Y; Slevin M; Smith N; Bailey J; Zweit J; Smith C; Ahmed N; Gaffney J
    Angiogenesis; 2001; 4(4):277-88. PubMed ID: 12197473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
    Hsia E; Richardson TP; Nugent MA
    J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library.
    Murphy PV; Pitt N; O'Brien A; Enright PM; Dunne A; Wilson SJ; Duane RM; O'Boyle KM
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3287-90. PubMed ID: 12392734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide.
    Dos Santos C; Blanc C; Elahouel R; Prescott M; Carpentier G; Ori A; Courty J; Hamma-Kourbali Y; Fernig DG; Delbé J
    Biochimie; 2014 Dec; 107 Pt B():350-7. PubMed ID: 25315978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.
    Ishihara J; Ishihara A; Starke RD; Peghaire CR; Smith KE; McKinnon TAJ; Tabata Y; Sasaki K; White MJV; Fukunaga K; Laffan MA; Lutolf MP; Randi AM; Hubbell JA
    Blood; 2019 Jun; 133(24):2559-2569. PubMed ID: 30975637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells.
    Brickman YG; Ford MD; Small DH; Bartlett PF; Nurcombe V
    J Biol Chem; 1995 Oct; 270(42):24941-8. PubMed ID: 7559620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A13-C2A binary complex structure-a key component in the acidic fibroblast growth factor for the non-classical pathway.
    Mohan SK; Rani SG; Kumar SM; Yu C
    Biochem Biophys Res Commun; 2009 Mar; 380(3):514-9. PubMed ID: 19284995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
    Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
    J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high throughput screening assay for inhibitors of fibroblast growth factor-receptor-heparin interactions.
    Aviezer D; Seddon AP; Wildey MJ; Böhlen P; Yayon A
    J Biomol Screen; 2001 Jun; 6(3):171-7. PubMed ID: 11689113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation.
    Tiefenbacher CP; Chilian WM
    Cardiovasc Res; 1997 May; 34(2):411-7. PubMed ID: 9205556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.